Boehringer to test obesity drug in three late-stage trials
Germany's Boehringer Ingelheim said on Thursday (Aug 17) it would conduct three late-stage studies for its obesity drug candidate after it showed up to...
Novo’s Wegovy shows heart benefit alongside weight loss in trial
Wegovy maker Novo Nordisk said on Tuesday (Aug 8) a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit,...
Weight-loss drugs pilot to begin in UK amid uncertainty over Wegovy launch
Britain plans to launch a pilot programme exploring how new weekly weight-loss shots such as Novo Nordisk's Wegovy can be given to obese patients by general...